首页
Enter Harbin medicine
Brand innovation
News trends
Harbin Pharmaceutical party building
Business cooperation
Social responsibility
Investor relations
Employer brand
Enter Harbin medicine
Brand innovation
News trends
Harbin Pharmaceutical party building
Business cooperation
Social responsibility
Investor relations
Employer brand
Harbin Pharmaceutical Group Co., LTD. (hereinafter referred to as "Harbin Pharmaceutical Group") is a large enterprise group integrating pharmaceutical manufacturing, trade and scientific research。Listed on the Shanghai Stock Exchange in June 1993 (stock code "600664"), it is the first listed company in the pharmaceutical industry in China and the first listed company in Heilongjiang Province。
The company covers two core business segments of pharmaceutical industry and pharmaceutical commerce，It owns Harbin Pharmaceutical Sanjing, Harbin Pharmaceutical General Factory, Harbin pharmaceutical sixth factory, Harbin Pharmaceutical Traditional Chinese Medicine and other industrial enterprises，Harbin Pharmaceutical People Tongtai (listed company), Harbin pharmaceutical marketing, Harbin pharmaceutical Health technology, GNC 4 commercial enterprises，It also has five R&D bases with strong scientific research force，Focus on chronic disease, anti-tumor, cardiovascular and cerebrovascular drugs and other high-tech fields of innovation and development。
Harbin Pharmaceutical shares have 1802 drug approvals and 122 health food approvals，Sales of over 100 million products include zinc gluconate oral solution, compound calcium gluconate oral solution, calcium iron zinc oral solution, Shuanghuanglian oral solution, amoxicillin capsules, lacidipine tablets, Roxatidine hydrochloride acetate for injection, recombinant human erythropoitin injection (CHO cells), children's acetaminophen granules, ibuprofen granules, etc。The company has "Harbin medicine", "three fine", "cover in cover", "Hutong", "World Hall" 5 well-known trademarks in China, the brand value of more than 20 billion yuan。
Harbin Pharmaceutical shares to "build a sustainable and healthy development of the century-old enterprise.，To become the benchmark of China's pharmaceutical and health industry "is the vision，To "provide good conscience medicine for public health.，Continue to improve people's health "as the mission，Adhering to the "integrity and professional, open and inclusive, collaborative responsibility, innovation and efficiency" corporate values，Build the pipeline layout for the full life cycle，Strengthen the digital communication of dominant brands，Comprehensively upgrade marketing channels and terminal control，Deepen lean production, high quality implementation to reduce costs and increase efficiency，Continue to build talent echelon。
Contact information
400-900-1111
Add: No. 7 Qunli Avenue, Daoli District, Harbin City, Heilongjiang Province Compliance report Email/Tel: compliance@taosihong.net / 0451-51870240
COPYRIGHT © 2013-2024 ALL RIGHTS RESERVED. Black ICP number 14002837 Harbin Pharmaceutical Group public number | Harbin Pharmaceutical Group Weibo
Internet Drug Information Service Qualification Certificate Number:(Black)- Non-operational -2017-0009 Black public network security 23010202010049